HCW Biologics is trading 6.5% down in after-hours trading at $2.96, with no confirmed catalyst identified.
- It closed at $3.17 on August 27, 2026, after a 17.41% regular-session gain.
- No new company-specific announcement dated August 27 was identified; the latest official investor-relations release located was the August 14 second-quarter update.
- The move contrasts with gains in major U.S. indexes and remains unclear.